MOTOR NEURONE DISEASE ASSOCIATION -  

Ranking results:

Past rankings:

2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2015-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2018 0 5.596.928 51.188 1
2015 0 5.980.435 0 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
HUMANITAS MIRASOLE2
THE UNIVERSITY OF SHEFFIELD2
ASSOCIATION GENETHON1
BRUSCHETTINI1
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE TOURS1
CENTRE HOSPITALIER UNIVERSITAIRE1
GOETEBORGS UNIVERSITET1
ICON CLINICAL RESEARCH LIMITED1
INSERM TRANSFERT1
ISTITUTO SUPERIORE DI SANITA1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KING'S COLLEGE LONDON1
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON1
THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN HEREINAFTER TRINITY COLLEGE DUBLIN1
THE UNIVERSITY OF SUSSEX1
UNIVERSITAET ULM1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT1
WGK CONSULTANCY1

Constancy:

Total number of partners: 20
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 20
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2018-01-01Safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS) TUDCA-ALSparticipant5.596.92810
2015-09-01Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients MIROCALSparticipant5.980.43512